Prion protein and Aβ‐related synaptic toxicity impairment

Cited by (242)

Items 101–200 of 242

1. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126
   Masahiro Kawahara, H. Koyama, Tetsuya Nagata, Yutaka Sadakane · 2011 · Metallomics
2. Glimepiride protects neurons against amyloid-β-induced synapse damage
   Craig Osborne, Ewan West, William Nolan, Harriet McHale-Owen, Alun Williams, Clive Bate · 2015 · Neuropharmacology
3. Initiation and propagation of neurodegeneration
   Christian Haass · 2010 · Nature Medicine
4. Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay
   Emmanuel Risse, Andrew J. Nicoll, William A. Taylor, Daniel Wright, Mayank Badoni, Xiaofan Yang, Mark A. Farrow, John Collinge · 2015 · Journal of Biological Chemistry
5. Prion protein and aging
   Lisa Gasperini, Giuseppe Legname · 2014 · Frontiers in Cell and Developmental Biology
6. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation
   Erin Bove‐Fenderson, Ryo Urano, John E. Straub, David A. Harris · 2017 · Journal of Biological Chemistry
7. Cellular Prion Protein Participates in Amyloid-β Transcytosis across the Blood—Brain Barrier
   Thorsten Pflanzner, Benjamin Petsch, Bettina André-Dohmen, Andreas Müller‐Schiffmann, Sabrina Tschickardt, Sascha Weggen, Lothar Stitz, Carsten Korth, Claus U. Pietrzik · 2012 · Journal of Cerebral Blood Flow & Metabolism
8. Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
   Irina Milisav, Dušan Šuput, Samo Ribarič · 2015 · Molecules
9. Synapses, Microglia, and Lipids in Alzheimer’s Disease
   Patrick Jarmo Paasila, Jason Abbas Aramideh, Greg Trevor Sutherland, Manuel B. Graeber · 2022 · Frontiers in Neuroscience
10. Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease
    Valeriy G. Ostapchenko, Flávio H. Beraldo, André Luiz Sena Guimarães, Sanju Mishra, Mónica S. Guzmán, Jue Fan, Vilma Regina Martins, Vânia F. Prado, Marco A. M. Prado · 2013 · Journal of Neurochemistry
11. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Drosophila model of Alzheimer's disease
    Nadine D. Younan, Ko‐Fan Chen, Ruth‐Sarah Rose, Damian C. Crowther, John H. Viles · 2018 · Journal of Biological Chemistry
12. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy
    Anna S. König, Nadine S. Rösener, Lothar Gremer, Markus Tusche, Daniel Flender, Elke Reinartz, Wolfgang Hoyer, Philipp Neudecker, Dieter Willbold, Henrike Heise · 2021 · Journal of Biological Chemistry
13. Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay
    Mino Kang, Su Yeon Kim, Seong Soo A. An, Young Ran Ju · 2013 · Experimental & Molecular Medicine
14. Prion protein in Alzheimer's pathogenesis: a hot and controversial issue
    Iryna Benilova, Bart De Strooper · 2010 · EMBO Molecular Medicine
15. Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer’s-Associated Aβ Oligomers
    Kyle C. Wilcox, Matthew R. Marunde, Aditi Das, Pauline T. Velasco, Benjamin D. Kuhns, Michael Thomas Marty, Jiang Haoming, Chi-Hao Luan, Stephen G. Sligar, William L. Klein · 2015 · PLoS ONE
16. Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies
    Luise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, Karl Frontzek, Julia Bär, Amulya Nidhi Shrivastava, Markus Daμμe, Feizhi Song, Alexander Schwarz, Stefano Da Vela et al. · 2021 · Science Advances
17. Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity
    Miyamoto, Takashi, Kim, Daniel, Knox, Joseph A., Johnson, Erik, Mucke, Lennart · 2016 · Journal of Biological Chemistry
18. Neuroprotective and Neurotoxic Signaling by the Prion Protein
    Ulrike K. Resenberger, Konstanze F. Winklhofer, Jörg Tatzelt · 2011 · Topics in current chemistry
19. Interaction between Prion Protein and Aβ Amyloid Fibrils Revisited
    Krzysztof Nieznański, Krystyna A. Surewicz, Shugui Chen, Hanna Nieznańska, Witold K. Surewicz · 2014 · ACS Chemical Neuroscience
20. Five Questions on Prion Diseases
    Adriano Aguzzi, Caihong Zhu · 2012 · PLoS Pathogens
21. Aβ Inhibition of Ionic Conductance in Mouse Basal Forebrain Neurons Is Dependent upon the Cellular Prion Protein PrPC
    Kwai A. Alier, Li Ma, Jing Yang, David A. Westaway, Jack H. Jhamandas · 2011 · Journal of Neuroscience
22. Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer
    Minkyung Lee, Hae‐June Lee, In Suh Park, Ji Ae Park, Yeon Kwon, Young Hoon Ryu, Chul Hoon Kim, Joo Hyun Kang, In Young Hyun, Kyo Chul Lee et al. · 2018 · Neuropharmacology
23. Neuroimmunoendocrine Regulation of the Prion Protein in Neutrophils
    Rafael Meyer Mariante, Alberto Nóbrega, Rodrigo A. P. Martins, Rômulo B. Areal, Maria Bellio, Rafael Linden · 2012 · Journal of Biological Chemistry
24. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1
    Pravas Kumar Baral, Barbara Wieland, Mridula Swayampakula, Magdalini Polymenidou, Muhammad Hafiz Rahman, Nat N. V. Kav, Adriano Aguzzi, Michael N.G. James · 2012 · Acta Crystallographica Section D Biological Crystallography
25. Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy
    Taeyeon Kim, Elvira Valera, Paula Desplats · 2019 · Molecular Neurobiology
26. Alzheimer’s Amyloid-β Oligomers Rescue Cellular Prion Protein Induced Tau Reduction via the Fyn Pathway
    Rong-Jie Chen, Wei-Wei Chang, Yu‐Chun Lin, Pei‐Lin Cheng, Yun‐Ru Chen · 2013 · ACS Chemical Neuroscience
27. LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer’s Disease
    Emma C. Pinnock, Katarina Jovanovic, Maxine G. Pinto, Eloise Ferreira, Bianca Da Costa Dias, Clement Brian Penny, Stefan H.J. Knackmuss, Uwe Reusch, Melvyn Little, Hermann M. Schätzl et al. · 2015 · Journal of Alzheimer s Disease
28. Domains of STIP1 responsible for regulating PrPC-dependent amyloid-β oligomer toxicity
    Andrzej Maciejewski, Valeriy G. Ostapchenko, Flávio H. Beraldo, Vânia F. Prado, Marco A. M. Prado, Wing‐Yiu Choy · 2016 · Biochemical Journal
29. Breaking the Code of Amyloid- β Oligomers
    Sylvain Lesné · 2013 · International Journal of Cell Biology
30. NCAM1 Polysialylation
    Mohadeseh Mehrabian, Herbert Hildebrandt, Gerold Schmitt‐Ulms · 2016 · ASN NEURO
31. Alzheimer's Disease and Prion Protein
    Jiayi Zhou · 2013 · Intractable & Rare Diseases Research
32. Prion protein and its role in signal transduction
    Alessandro Didonna · 2013 · Cellular & Molecular Biology Letters
33. Endogenous Prion Protein Attenuates Experimentally Induced Colitis
    Gary R. Martin, Catherine M. Keenan, Keith A. Sharkey, Frank Robert Jirik · 2011 · American Journal Of Pathology
34. Role of cellular prion protein in interneuronal amyloid transmission
    José Antonio del Rı́o, Isidró Ferrer, Rosalina Gavı́n · 2018 · Progress in Neurobiology
35. Insoluble cellular prion protein and its association with prion and Alzheimer diseases
    Wen‐Quan Zou, Xiaochen Zhou, Jue Yuan, Xiangzhu Xiao · 2011 · Prion
36. Cellular Prion Protein Mediates Toxic Signaling of Amyloid Beta
    Ulrike K. Resenberger, Konstanze F. Winklhofer, Jörg Tatzelt · 2011 · Neurodegenerative Diseases
37. Endogenous prion protein conversion is required for prion‐induced neuritic alterations and neuronal death
    Sabrina Cronier, Julie Carimalo, Brigitte Schaeffer, Emilie Jaumain, Vincent Béringue, Marie‐Christine Miquel, Hubert Laude, Jean‐Michel Peyrin · 2012 · The FASEB Journal
38. Prion protein oligomer and its neurotoxicity
    Pei Huang, Fulin Lian, Yi Wen, Chenyun Guo, Donghai Lin · 2013 · Acta Biochimica et Biophysica Sinica
39. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases
    Giuseppe Legname, Carlo Scialò · 2020 · Prion
40. Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View
    Christiaan F. M. Huffels, Jinte Middeldorp, Elly M. Hol · 2022 · Neurochemical Research
41. β-amyloid oligomers and prion protein
    Gianluigi Forloni, Claudia Balducci · 2011 · Prion
42. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein
    Nadine S. Rösener, Lothar Gremer, Elke Reinartz, Anna König, Oleksandr Brener, Henrike Heise, Wolfgang Hoyer, Philipp Neudecker, Dieter Willbold · 2018 · Journal of Biological Chemistry
43. The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain
    Rosalina Gavı́n, Laia Lidón, Isidró Ferrer, José Antonio del Rı́o · 2020 · Cells
44. Impact of the Cellular Prion Protein on Amyloid-β and 3PO-Tau Processing
    Matthias Schmitz, Katharina Wulf, Sandra C. Signore, Walter Schulz‐Schaeffer, Pawel Kermer, Mathias Bähr, Fred Silvester Wouters, Saima Zafar, Inga Zerr · 2013 · Journal of Alzheimer s Disease
45. Genome‐wide identification of microRNAs regulating the human prion protein
    Daniel Pease, Claudia Scheckel, Elke Schaper, Valeria Eckhardt, Marc Emmenegger, Ioannis Xénarios, Adriano Aguzzi · 2018 · Brain Pathology
46. Overexpression of cellular prion protein (PrPC) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-β (Aβ1–40) administration in mice
    Daniel Rial, Tetsade Piermartiri, Filipe Silveira Duarte, Carla I. Tasca, Roger Walz, Rui Daniel Prediger · 2012 · Neuroscience
47. The cellular prion protein beyond prion diseases
    Giorgia Manni, Victoria Lewis, Matteo Senesi, Giovanni Spagnolli, Francesca Fallarino, Steven John Collins, Sophie Mouillet‐Richard, Emiliano Biasini · 2020 · Swiss Medical Weekly
48. Prion protein and prion disease at a glance
    Caihong Zhu, Adriano Aguzzi · 2021 · Journal of Cell Science
49. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein
    Priyanka Madhu, Samrat Mukhopadhyay · 2019 · ACS Chemical Neuroscience
50. Immunization with either prion protein fragment 95–123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice
    Natalia V. Bobkova, Natalia I. Medvinskaya, A. V. Kamynina, I. Yu. Aleksandrova, I. V. Nesterova, Alexander N. Samokhin, Dmitriy O. Koroev, М. П. Филатова, Pavel V. Nekrasov, Andrey Y. Abramov et al. · 2013 · Neurobiology of Learning and Memory
51. Shedding light on prion disease
    Markus Glatzel, Luise Linsenmeier, Frank Dohler, Susanne Krasemann, Berta Puig, Hermann C. Altmeppen · 2015 · Prion
52. Regulation of amyloid-β production by the prion protein
    Heledd Jarosz-Griffiths, Isobel J. Whitehouse, Nigel M. Hooper · 2012 · Prion
53. Possible role for Ca2+ in the pathophysiology of the prion protein?
    Caterina Peggion, Alessandro Bertoli, Maria Catia Sorgato · 2011 · BioFactors
54. Functions of the cellular prion protein, the end of Moore's law, and Ockham's razor theory
    José Antonio del Rı́o, Rosalina Gavı́n · 2016 · Prion
55. The multiple functions of PrPC in physiological, cancer, and neurodegenerative contexts
    Izabella Grimaldi, Felipe Saceanu Leser, José Marcos Janeiro, Bárbara Gomes da Rosa, Ana Clara Campanelli, Luciana Ferreira Romão, Flávia Regina Souza Lima · 2022 · Journal of Molecular Medicine
56. Unaltered prion protein expression in Alzheimer disease patients
    Eri Saijo, Stephen W. Scheff, Glenn C. Telling · 2011 · Prion
57. Hijacking PrPc-dependent signal transduction: when prions impair Aβ clearance
    Julia Hernandez-Rapp, Severine Martin‐Lannerée, Théo Z. Hirsch, Jean‐Marie Launay, Sophie Mouillet‐Richard · 2014 · Frontiers in Aging Neuroscience
58. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition
    Thomas L. Williams, Jin-Kyu Choi, Krystyna A. Surewicz, Witold K. Surewicz · 2015 · ACS Chemical Neuroscience
59. Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation
    Behnam Mohammadi, Luise Linsenmeier, Mohsin Shafiq, Berta Puig, Giovanna Galliciotti, Camilla Giudici, Michael Willem, Thomas Watts Eden, Friedrich Koch‐Nolte, Yu-Hsuan Lin et al. · 2020 · Molecular Neurobiology
60. Unraveling the neuroprotective mechanisms of PrP C in excitotoxicity
    Franc Llorens, José Antonio del Rı́o · 2012 · Prion
61. Lipid rafts: linking prion protein to zinc transport and amyloid-β toxicity in Alzheimer's disease
    Nicole T. Watt, Heledd Jarosz-Griffiths, Nigel M. Hooper · 2014 · Frontiers in Cell and Developmental Biology
62. Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice
    Lara Ordóñez‐Gutiérrez, Juan María Torres, Rosalina Gavı́n, Marta Antón, Ana I. Arroba, Juan Carlos Espinosa, Cristina Vergara, José Antonio del Rı́o, Francisco G. Wandosell · 2013 · Neurobiology of Aging
63. Immunomodulation for prion and prion-related diseases
    Thomas Wısnıewskı, Fernando Goñi · 2010 · Expert Review of Vaccines
64. Inhibition of the FKBP family of peptidyl prolyl isomerases induces abortive translocation and degradation of the cellular prion protein
    Paweł Stocki, Maxime Sawicki, Charles E. Mays, Seo Jung Hong, Daniel C. Chapman, David A. Westaway, David B. Williams · 2016 · Molecular Biology of the Cell
65. Rescuing neurons in prion disease
    Nicholas Verity, Giovanna R. Mallucci · 2010 · Biochemical Journal
66. Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy
    Hanna Nieznańska, Magdalena Bandyszewska, Krystyna A. Surewicz, Tomasz Zajkowski, Witold K. Surewicz, Krzysztof Nieznański · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
67. Overcoming barriers and thresholds – signaling of oligomeric Aβ through the prion protein to Fyn
    Hansen Wang, Carl He Ren, C. Geeth Gunawardana, Gerold Schmitt‐Ulms · 2013 · Molecular Neurodegeneration
68. Neurodegeneration and Unfolded-Protein Response in Mice Expressing a Membrane-Tethered Flexible Tail of PrP
    Paolo Dametto, Asvin KK Lakkaraju, Claire Bridel, Lukas Villiger, Tracy O’Connor, U. Herrmann, Paweł Pelczar, Thomas Rülicke, Donal McHugh, Arlind Adili et al. · 2015 · PLoS ONE
69. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease
    Chang Kong, Hao Xie, Zhenxing Gao, Ming Shao, Huan Li, Run Shi, Lili Cai, Shanshan Gao, Taolei Sun, Chaoyang Li · 2019 · Virologica Sinica
70. Bis(ethylmaltolato)oxidovanadium (IV) mitigates neuronal apoptosis resulted from amyloid-beta induced endoplasmic reticulum stress through activating peroxisome proliferator-activated receptor γ
    Zhijun He, Meng-Huan Wang, Qionghui Zhao, Xiaoqian Li, Pengan Liu, Bingyu Ren, Chong Wu, Xiubo Du, Nan Li, Qiong Liu · 2020 · Journal of Inorganic Biochemistry
71. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques
    Machhindra Garad, Elke Edelmann, Volkmar Leßmann · 2021 · International Journal of Molecular Sciences
72. Prion protein expression alters APP cleavage without interaction with BACE-1
    Patrick McHugh, Josephine A. Wright, Robert J. Williams, David R. Brown · 2012 · Neurochemistry International
73. Cross‐Talk Between the Octarepeat Domain and the Fifth Binding Site of Prion Protein Driven by the Interaction of Copper(II) with the N‐terminus
    Giuseppe Di Natale, Ildikó Turi, Giuseppe Pappalardo, Imre Sóvágó, Enrico Rizzarelli · 2015 · Chemistry - A European Journal
74. Tau oligomers impair memory and synaptic plasticity through the cellular prion protein
    Claudia Balducci, Franca Orsini, Milica Cerovic, Marten Beeg, Beatrice Rocutto, Letizia Dacomo, Antonio Masone, Eleonora Busani, Ilaria Raimondi, Giada Lavigna et al. · 2025 · Acta Neuropathologica Communications
75. Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP
    Akikazu Sakudo, Takashi Onodera · 2015 · Frontiers in Cell and Developmental Biology
76. Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease
    Susan Bullman, Matthew M. Meyerson, Aleksandar David Kostic · 2016 · Annual Review of Pathology Mechanisms of Disease
77. Cellular Prion Protein Expression Is Not Regulated by the Alzheimer's Amyloid Precursor Protein Intracellular Domain
    Victoria Lewis, Isobel J. Whitehouse, Herbert N. Baybutt, Jean C. Manson, Steven John Collins, Nigel M. Hooper · 2012 · PLoS ONE
78. Soluble Aβ aggregates can inhibit prion propagation
    Claire J. Sarell, Emma Quarterman, Daniel Chun-Mun Yip, Cassandra Terry, Andrew J. Nicoll, Jonathan D. F. Wadsworth, Mark A. Farrow, Dominic M. Walsh, John Collinge · 2017 · Open Biology
79. Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype
    Isobel J. Whitehouse, Deborah Brown, Herbert N. Baybutt, Abigail B. Diack, Katherine A. B. Kellett, Pedro Piccardo, Jean C. Manson, Nigel M. Hooper · 2016 · PLoS ONE
80. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein
    Behnam Mohammadi, Feizhi Song, Andreu Matamoros‐Angles, Mohsin Shafiq, Markus Daμμe, Berta Puig, Markus Glatzel, Hermann C. Altmeppen · 2022 · Cell and Tissue Research
81. Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review
    Emily Dexter, Qingzhong Kong · 2021 · Expert Review of Neurotherapeutics
82. Prion, prionoids and infectious amyloid
    Pawel Piotr Liberski · 2013 · Parkinsonism & Related Disorders
83. Prion Diseases
    Benjamin C. Whitechurch, Jeremy M. Welton, Steven John Collins, Victoria Lawson · 2017 · Advances in neurobiology
84. The P’s and Q’s of cellular PrP-Aβ interactions
    David A. Westaway, Jack H. Jhamandas · 2012 · Prion
85. The neurodegeneration in Alzheimer disease and the prion protein
    Gianluigi Forloni, Alessandra Sclip, Tiziana Borsello, Claudia Balducci · 2013 · Prion
86. Prion diseases: New considerations
    Ádám Annus, Anett Csáti, László Vécsei · 2016 · Clinical Neurology and Neurosurgery
87. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates
    Carlo Scialò, Giuseppe Legname · 2020 · Progress in molecular biology and translational science
88. Cellular prion protein and Alzheimer disease
    Wataru Kudo, Robert B. Petersen, Hyoung‐gon Lee · 2013 · Prion
89. Protease Resistant Protein Cellular Isoform (PrPc) as a Biomarker: Clues into the Pathogenesis of HAND
    Bezawit Megra, Eliseo Eugenin, Toni Kay Roberts, Susan Morgello, Joan W. Berman · 2013 · Journal of Neuroimmune Pharmacology
90. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases
    Nunzio Iraci, Claudia Stincardini, Maria Letizia Barreca, Emiliano Biasini · 2014 · Virus Research
91. “Dual Disease” TgAD/GSS mice exhibit enhanced Alzheimer’s disease pathology and reveal PrPC-dependent secretion of Aβ
    Kefeng Qin, Lili Zhao, Crystal Gregory, Ani Solanki, James A. Mastrianni · 2019 · Scientific Reports
92. Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease
    Lauren Owens, Alexandre Benedetto, Neil Dawson, Christopher J. Gaffney, Edward T. Parkin · 2021 · Brain Research
93. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases
    Maxime Béland, Xavier Roucou · 2013 · Prion
94. Key Alzheimer's findings questioned
    Heidi K. Ledford · 2010 · Nature
95. Altered synaptic glutamate homeostasis contributes to cognitive decline in young APP/PSEN1 mice
    Jordyn M. Wilcox, David C. Consoli, Adriana A. Tienda, Shilpy Dixit, R.A. Buchanan, James Michael May, William P. Nobis, Fiona Edith Harrison · 2021 · Neurobiology of Disease
96. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
    Feizhi Song, Valerija Kovač, Behnam Mohammadi, Jessica Lisa Littau, Franka Scharfenberg, Andreu Matamoros‐Angles, Ilaria Vanni, Mohsin Shafiq, Leonor Orge, Giovanna Galliciotti et al. · 2024 · Acta Neuropathologica
97. Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development
    Emily Dexter, Qingzhong Kong · 2021 · Expert Review of Neurotherapeutics
98. New Drosophila models to uncover the intrinsic and extrinsic factors that mediate the toxicity of the human prion protein
    Ryan R. Myers, Jonatan Sanchez-Garcia, Daniel C. Levings, Richard G. Melvin, Pedro Fernández-Fúnez · 2022 · Disease Models & Mechanisms
99. Oligomeropathies, inflammation and prion protein binding
    Gianluigi Forloni, Pietro La Vitola, Claudia Balducci · 2022 · Frontiers in Neuroscience
100. Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis
     Giuseppe Scalabrino, Daniela Veber · 2013 · Journal of Neurology